Figure 4
From: Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
Comparison of survival of patients with complete histopathological eradication of the primary tumor lesion post NT (T0) and those with residual viable tumor cells (T1-4). Median survival time was 27.8 and 13.6 months, respectively.
